Skip to main content
Equibles

BARCLAYS PLC

Position in HUMA — Humacyte, Inc.

CIK 312069 LONDON, X0
Back to HUMA Full portfolio

Position in HUMA

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$30,950
+$6,582 QoQ
Shares Held
39,680
-1.2% QoQ
Ownership
0.014%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#74
of 163 holders
Holding Since
Mar 2022
18 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in HUMA Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

BARCLAYS PLC holds $1,710,275,600 across 455 Biotechnology names. HUMA ranks #298 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 733,274 $364,239,192
2 REGN
Regeneron Pharmaceuticals, Inc.
 256,192 $159,745,957
3 IONS
Ionis Pharmaceuticals Inc
 1,603,136 $127,112,653
4 ARGX
Argenx SE
 134,427 $124,717,337
5 MRNA
Moderna, Inc.
 1,035,126 $72,489,872
6 BBIO
BridgeBio Pharma, Inc.
 714,423 $53,210,224
7 TGTX
Tg Therapeutics, Inc.
 957,848 $52,624,168
8 DNTH
Dianthus Therapeutics, Inc. /DE/
 431,753 $42,087,281

All Filings in HUMA

Export CSV
18 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $30,950 39,680
2026-03-31 $24,368 40,147
2025-12-31 $701,018 729,469
2025-09-30 $318,381 182,978
2025-06-30 $925,825 442,979
2025-03-31 $331,842 194,629
2024-12-31 $1,142,643 226,266
2024-09-30 $1,287,876 236,742
2024-06-30 $409,363 85,284
2024-03-31 $208,261 66,965
2023-12-31 $276,011 97,187
2023-09-30 $69,698 23,788
2023-06-30 $202,610 70,843
2023-03-31 $136,738 44,252
2022-12-31 $63,525 30,107
2022-09-30 $49,131 15,071
2022-06-30 $48,817 15,208
2022-03-31 $102,800 14,561